Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intra-prostatic recurrences after radiotherapy with focal boost: Location and dose mapping in the FLAME trial.
Menne Guricová K, Pos FJ, Schoots IG, Vogel WV, Kerkmeijer LGW, Monninkhof EM, de Boer JCJ, van der Voort van Zyp JRN, Kunze-Busch M, Smeenk RJ, Draulans C, Haustermans K, van Houdt PJ, van der Heide UA. Menne Guricová K, et al. Among authors: van der voort van zyp jrn. Radiother Oncol. 2024 Dec;201:110535. doi: 10.1016/j.radonc.2024.110535. Epub 2024 Sep 13. Radiother Oncol. 2024. PMID: 39278316 Clinical Trial.
Conventional versus automated implantation of loose seeds in prostate brachytherapy: analysis of dosimetric and clinical results. In regard to Genebes et al.
Moerland MA, Maenhout M, van der Voort van Zyp JR, Noteboom JL, Eppinga WS, van Vulpen M, Monninkhof EM, Verkooijen HM. Moerland MA, et al. Int J Radiat Oncol Biol Phys. 2014 Jun 1;89(2):436-7. doi: 10.1016/j.ijrobp.2014.02.020. Epub 2014 May 5. Int J Radiat Oncol Biol Phys. 2014. PMID: 24837898 No abstract available.
Prostate tumor delineation using multiparametric magnetic resonance imaging: Inter-observer variability and pathology validation.
Steenbergen P, Haustermans K, Lerut E, Oyen R, De Wever L, Van den Bergh L, Kerkmeijer LG, Pameijer FA, Veldhuis WB, van der Voort van Zyp JR, Pos FJ, Heijmink SW, Kalisvaart R, Teertstra HJ, Dinh CV, Ghobadi G, van der Heide UA. Steenbergen P, et al. Radiother Oncol. 2015 May;115(2):186-90. doi: 10.1016/j.radonc.2015.04.012. Epub 2015 Apr 29. Radiother Oncol. 2015. PMID: 25935742 Free article.
MRI-guided prostate adaptive radiotherapy - A systematic review.
McPartlin AJ, Li XA, Kershaw LE, Heide U, Kerkmeijer L, Lawton C, Mahmood U, Pos F, van As N, van Herk M, Vesprini D, van der Voort van Zyp J, Tree A, Choudhury A; MR-Linac consortium. McPartlin AJ, et al. Radiother Oncol. 2016 Jun;119(3):371-80. doi: 10.1016/j.radonc.2016.04.014. Epub 2016 May 6. Radiother Oncol. 2016. PMID: 27162159 Review.
MRI guided focal HDR brachytherapy for localized prostate cancer: Toxicity, biochemical outcome and quality of life.
Maenhout M, Peters M, Moerland MA, Meijer RP, van den Bosch MAAJ, Frank SJ, Nguyen PL, van Vulpen M, van der Voort van Zyp JRN. Maenhout M, et al. Among authors: van der voort van zyp jrn, van vulpen m, van den bosch maaj. Radiother Oncol. 2018 Dec;129(3):554-560. doi: 10.1016/j.radonc.2018.07.019. Epub 2018 Aug 18. Radiother Oncol. 2018. PMID: 30131183
99 results